2020
DOI: 10.1016/j.amjcard.2020.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and Outcomes of Pericardial Effusion in Kidney Transplant Candidates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 12 publications
2
4
0
Order By: Relevance
“…Pericardial effusion may occur after acute myocardial infarction. In a previous cohort study, pericardial effusion was found in 28% of patients with acute myocardial infarction [7]. In this study, we found that 11% of patients had a history of myocardial infarction.…”
Section: Discussionsupporting
confidence: 58%
“…Pericardial effusion may occur after acute myocardial infarction. In a previous cohort study, pericardial effusion was found in 28% of patients with acute myocardial infarction [7]. In this study, we found that 11% of patients had a history of myocardial infarction.…”
Section: Discussionsupporting
confidence: 58%
“…The findings suggested that the duration of hemodialysis was a key protective factor against developing moderate to large PE. Patients in this study were followed for an average of 39 months, revealing a 10-year survival rate of 87%, indicating a favorable prognosis [ 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…Although the risk of drainage in PE is influenced by its severity, directly comparing our results with their study is challenging due to differences in population groups, methodologies, and data reporting. Additionally, some studies report no significant relationship between serum albumin and PE in mixed populations of dialysis and non-dialysis CKD patients [ 31 , 35 ], further illustrating the variability in findings across different research contexts.…”
Section: Discussionmentioning
confidence: 99%
“…[ 26 ] Uremic pericarditis, pericardial effusion and chronic left heart failure were common clinical manifestations in patients with end stage renal disease. [ 27 ] It was suggested that accumulation of toxic metabolites may play an important role in cardiovascular damage in end stage renal disease patients. [ 28 ] These studies showed that there were close relationships between cardiovascular involvement and renal involvement in AAV patients.…”
Section: Discussionmentioning
confidence: 99%
“…The tryptophan may also cause atherosclerosis through the release of reactive oxygen species that cause endothelial damage [26] . Uremic pericarditis, pericardial effusion and chronic left heart failure were common clinical manifestations in patients with end stage renal disease [27] . It was suggested that accumulation of toxic metabolites may play an important role in cardiovascular damage in end stage renal disease patients [28] .…”
Section: Discussionmentioning
confidence: 99%